Digol, Loraine B.
HRN: 13-76-20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2024
CEFUROXIME 750MG (VIAL)
06/01/2024
06/08/2024
IV
750mg
Q8H
UTI
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes